News & Publications

  • June 24, 2026||News||

    MCC Therapeutics, Inc. will present Phase 1 Clinical Results of MCCSA2 at the World Bronchiectasis Conference (WBC2026) in Hanover, Germany

    Read MoreRead More
  • June 5, 2026||News||

    MCC Therapeutics announces the Publication of its Scientists’ Paper in the Journal of Clinical Investigation

  • October 7, 2025||News||

    New hope from old drugs for cystic fibrosis: startup explores combination therapy

  • September 15, 2025||Annual Update||

    Annual Update for 2025